HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Philips, B J Articles by Baker, E H Search for Related Content PubMed PubMed Citation Articles by Philips, B J Articles by Baker, E H Topic Collections Relevant Article

Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients

¹ Glucose and Pulmonary Infection Group, Jenner Wing, St George’s Hospital Medical School, London SW17 0RE, UK
² Department of Anaesthesia, York Health Services NHS Trust, York YO31 8HE, UK
³ Department of Microbiology, Jenner Wing, St George’s Hospital Medical School, London SW17 0RE, UK

Correspondence to:
Correspondence to:
Dr B J Philips
Glucose and Pulmonary Infection Group, Jenner Wing, St George’s Hospital Medical School, London SW17 0RE, UK; bphilips{at}sghms.ac.uk

Background: The risk of nosocomial infection is increased in critically ill patients by stress hyperglycaemia. Glucose is not normally detectable in airway secretions but appears as blood glucose levels exceed 6.7–9.7 mmol/l. We hypothesise that the presence of glucose in airway secretions in these patients predisposes to respiratory infection.

Methods: An association between glucose in bronchial aspirates and nosocomial respiratory infection was examined in 98 critically ill patients. Patients were included if they were expected to require ventilation for more than 48 hours. Bronchial aspirates were analysed for glucose and sent twice weekly for microbiological analysis and whenever an infection was suspected.

Results: Glucose was detected in bronchial aspirates of 58 of the 98 patients. These patients were more likely to have pathogenic bacteria than patients without glucose detected in bronchial aspirates (relative risk 2.4 (95% CI 1.5 to 3.8)). Patients with glucose were much more likely to have methicillin resistant Staphylococcus aureus (MRSA) than those without glucose in bronchial aspirates (relative risk 2.1 (95% CI 1.2 to 3.8)). Patients who became colonised or infected with MRSA had more infiltrates on their chest radiograph (p<0.001), an increased C reactive protein level (p<0.05), and a longer stay in the intensive care unit (p<0.01). Length of stay did not determine which patients acquired MRSA.

Conclusion: The results imply a relationship between the presence of glucose in the airway and a risk of colonisation or infection with pathogenic bacteria including MRSA.

Abbreviations: ARDS, acute respiratory distress syndrome; GLUT, glucose transporter; MRSA, methicillin resistant Staphylococcus aureus; SGLT1, sodium glucose co-transporter-1; SOFA, sequential organ failure assessment; SSA, sensitive Staphylococcus aureus

Keywords: glucose; hyperglycaemia; methicillin resistant Staphylococcus aureus; respiratory tract infections; critical care

Relevant Article

Airwaves

Wisia Wedzicha
Thorax 2005 60: 709a. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				R. L. Derr, V. C. Hsiao, and C. D. Saudek Antecedent Hyperglycemia Is Associated With an Increased Risk of Neutropenic Infections During Bone Marrow Transplantation Diabetes Care, October 1, 2008; 31(10): 1972 - 1977. [Abstract] [Full Text] [PDF]

				E. H. Baker, N. Clark, A. L. Brennan, D. A. Fisher, K. M. Gyi, M. E. Hodson, B. J. Philips, D. L. Baines, and D. M. Wood Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis J Appl Physiol, May 1, 2007; 102(5): 1969 - 1975. [Abstract] [Full Text] [PDF]

				EmmaH. Baker, A. Irwin, AmandaL. Brennan, B. Trost, A. Britten, S. Heenan, and B. Peterson Development of a biomarker for lung inflammation in COPD through analysis of labelled leukocyte transit through the lung circulation Eur. Respir. Rev., December 1, 2006; 15(101): 170 - 171. [Abstract] [Full Text] [PDF]

				S J Finney and T W Evans Tight glycaemic control in acute exacerbations of COPD. Thorax, April 1, 2006; 61(4): 275 - 279. [Full Text] [PDF]

				E H Baker, C H Janaway, B J Philips, A L Brennan, D L Baines, D M Wood, and P W Jones Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease Thorax, April 1, 2006; 61(4): 284 - 289. [Abstract] [Full Text] [PDF]

				R. A Medina, E. Baker, B. Philips, A. Woollhead, and D. Baines Glucose Transport in H441 Lung Epithelial Cells FASEB J, March 1, 2006; 20(4): A348 - A348. [Abstract] [Full Text]

				G. I Varughese, K. Miltsios, H. N Buch, J. M Orendi, and J. H. Scarpello Mortality rates in hospital patients with hyperglycaemia and MRSA bacteraemia The British Journal of Diabetes & Vascular Disease, January 1, 2006; 6(1): 42 - 44. [Abstract] [PDF]

				J S Brown Glucose, bronchial secretions and MRSA Thorax, September 1, 2005; 60(9): 711 - 712. [Full Text] [PDF]